While the fabled fountain of youth may not actually exist, a new type of therapy now does.
Benitec Biopharma Inc. reports 100% responder rates for BB-301 with a mid-2026 FDA meeting ahead. See why BNTC stock is upgraded to buy.
PHILADELPHIA, PA — Aro Biotherapeutics said it will present interim clinical data next month from its ongoing Phase 1b trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results